NEW YORK, Sept. 7, 2016 /PRNewswire/ -- Spheryx, Inc. announced today that the National Science Foundation (NSF) has awarded the company a Phase II Small Business Innovation Research (SBIR) grant for $748,000 to support commercialization of their proprietary Total Holographic Characterization® technology. These highly competitive grants are intended to stimulate technological innovation and commercialization for small businesses.
Early applications of this technology include product development, quality assurance and process control in the semiconductor manufacturing and biologic pharmaceuticals industries. A beta version of the instrument will be available for sale in 2017 to select customer/partner companies.
Dr. Laura Philips, Founder, President and CEO commented, "This Phase II SBIR award is a testament to the power of the technology to provide solutions to critical problems in major industry sectors where Total Holographic Characterization® has the potential to enhance innovation, improve performance, increase quality and decrease manufacturing costs. The successful completion of the proof-of-principle work completed under a Phase I grant makes us confident that the support of this Phase II grant will enable Spheryx to deliver this powerful new technology to the market."
About Spheryx, Inc.
Spheryx, Inc. is a privately held company developing Total Holographic Characterization®. This breakthrough proprietary technology uses holographic video microscopy to characterize particles in colloidal dispersions and multi-component colloidal mixtures, thereby offering unprecedented insights into materials' characteristics. Applications include research and development, quality assurance and manufacturing process control across a broad spectrum of industries, where characterization of colloids can enhance innovation, improve safety and reduce costs. For more information please visit the company's website at www.spheryx.solutions
Note: This news release contains forward-looking statements regarding future events. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or result to differ materially. These risks and uncertainties include, among others: the results, timing and costs of our studies; our ability to obtain future funding on acceptable terms; the possible impairment of, or inability to obtain intellectual property rights; and innovation by our competitors.
Laura Philips, CEO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/spheryx-awarded-phase-ii-nsf-sbir-grant-to-support-commercialization-of-total-holographic-characterization-300323612.html
SOURCE Spheryx, Inc.